According to the ASCO Clinical Practice Guideline update of Fertility Preservation in Patients with Cancer in 2018, aromatase inhibitor–based stimulation protocols are now well established and may ameliorate the concern of FP’s influence on cancer. The gene discussed is CYP19A1; the disease is cancer.